Company intelligence / Profile preview

Immunology Partners

Gaithersburg, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Immunology Partners was a U.S. healthcare diagnostics company focused on novel tests for measuring immune function. Available evidence indicates the company operated in Maryland and was described by investors as developing diagnostics intended to assess immune system status rather than therapeutic drug programs. The business appears to have been venture-backed and associated with healthcare investor Stephen Bloch. Public bankruptcy records indicate the company filed for Chapter 11 bankruptcy in December 2012, so it does not appear to be an active operating company today. Little recent public information is available on products, pipeline, or commercialization after that filing.

Therapeutic areas: Immunology
Modalities: Diagnostic assay
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Immunology Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunology Partners.

Explore the full profile